Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italia...
Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas
About this item
Full title
Author / Creator
Roberto, Giuseppe , Barone-Adesi, Francesco , Giorgianni, Francesco , Pizzimenti, Valeria , Ferrajolo, Carmen , Tari, Michele , Bartolini, Claudia , Da Cas, Roberto , Maggini, Marina , Spila-Alegiani, Stefania , Francesconi, Paolo , Trifirò, Gianluca , Poluzzi, Elisabetta , Baccetti, Fabio and Gini, Rosa
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The incretin-based medicines GLP1 analogues (GLP1a) and dipeptidyl peptidase-4 inhibitors (DPP4i) are hypoglycaemic agents licensed for the treatment of type 2 diabetes mellitus (T2DM). Although these drugs possess comparable efficacy and low risk of hypoglycaemia, differences in terms of route of administration (subcutaneous versus oral), effect o...
Alternative Titles
Full title
Patterns and trends of utilization of incretin-based medicines between 2008 and 2014 in three Italian geographic areas
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_04a605883ebf4f0e99f14d8bc520baef
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_04a605883ebf4f0e99f14d8bc520baef
Other Identifiers
ISSN
1472-6823
E-ISSN
1472-6823
DOI
10.1186/s12902-019-0334-y
